Skip to main content
Glama

Entity Profile

entity_profile
Read-onlyIdempotent

"Tell me about X" / "research Acme" / "brief me on Tesla" / "what does Apple do" / "company profile for Microsoft" / "give me the rundown on NVDA" / "everything you know about $TICKER" — full cross-source profile of a US public company in ONE parallel call. ALWAYS PREFER over chaining single-pack SEC/XBRL/news lookups when the user asks for a holistic view. Fans out across SEC EDGAR, XBRL, USPTO patents, federal contracts (USAspending), FDA-licensed biologics (Purple Book), H-1B hiring (DOL LCA), news and GLEIF, and returns: cik + company_name (+ resolved_from/resolved_to when value was a name); recent_filings (up to 5 with pipeworx://edgar/company/{cik}/filings/{accession} URIs); fundamentals (LATEST 10-K Revenues + NetIncomeLoss + Cash, sorted period_end DESC); patents (USPTO PatentsView API sunset May 2025 — soft-fails until reactivated); federal_contracts (USAspending awards where the company is the recipient); fda_products (FDA-licensed biologics — vaccines, cell/gene therapies — from the Purple Book; a company with only small-molecule/generic drugs will show none here, that is expected, not a failure); hiring (H-1B sponsorship volume + salary range from DOL LCA filings); recent news mentions via GDELT→GNews fallback; LEI via GLEIF. sources_used / sources_failed say which of these actually returned data for THIS company — an empty section is a real "no data", not a bug. Pass a ticker ("AAPL"), zero-padded CIK ("0000320193"), OR a company name ("Moderna") — names now resolve via SEC EDGAR's company-name match; a private company (no CIK/ticker) returns resolved:false with an explicit notes line, not a bare failure. type accepts "company" or "ticker" interchangeably — both take the same value shapes above.

Input Schema

TableJSON Schema
NameRequiredDescriptionDefault
typeYes"company" or "ticker" — both are accepted and behave identically; `value` can be a ticker, CIK, or company name either way. person/place coming soon.
valueYesTicker (e.g., "AAPL"), zero-padded CIK (e.g., "0000320193"), or company name (e.g., "Moderna") — names resolve via SEC EDGAR company-name match.

Schema Changelog

Changes observed during successful MCP inspections. Dates show when Glama detected each change.

  1. Changed3 schema fields changed
    • changedInput schema / properties / type / description
      Previous value: -"Entity type. Only \"company\" supported today; person/place coming soon."New value: +"\"company\" or \"ticker\" — both are accepted and behave identically; `value` can be a ticker, CIK, or company name either way. person/place coming soon."
    • changedInput schema / properties / type / enum
      Previous value: -[
      -  "company"
      -]New value: +[
      +  "company",
      +  "ticker"
      +]
    • changedInput schema / properties / value / description
      Previous value: -"Ticker (e.g., \"AAPL\") or zero-padded CIK (e.g., \"0000320193\"). Names not supported — use resolve_entity first if you only have a name."New value: +"Ticker (e.g., \"AAPL\"), zero-padded CIK (e.g., \"0000320193\"), or company name (e.g., \"Moderna\") — names resolve via SEC EDGAR company-name match."
  2. First observed

TDQS

A4.6/5.0
Behavior5/5

Does the description disclose side effects, auth requirements, rate limits, or destructive behavior?

Annotations already establish read-only, idempotent, non-destructive behavior; the description adds substantial behavioral context: parallel fan-out, sources_used/sources_failed semantics, soft-failure for the sunset USPTO API, and the meaning of an empty section as real 'no data.' It also explains that FDA biologics may be absent for normal drug companies, which prevents misinterpretation.

Agents need to know what a tool does to the world before calling it. Descriptions should go beyond structured annotations to explain consequences.

Conciseness4/5

Is the description appropriately sized, front-loaded, and free of redundancy?

The description is long but information-dense, with query examples up front and each sentence carrying behavioral, scoping, or error-handling value. It lacks clear paragraph breaks and reads as one run-on block, but there is no filler or redundant explanation beyond reinforcing the schema examples.

Shorter descriptions cost fewer tokens and are easier for agents to parse. Every sentence should earn its place.

Completeness5/5

Given the tool's complexity, does the description cover enough for an agent to succeed on first attempt?

Despite having no output schema, the description enumerates return components (CIK, company_name, files, fundamentals, sources_used/failed), covers edge cases like private companies and soft-failed sources, and clarifies expected behaviors across all fan-out endpoints. An agent is well-equipped to invoke the tool and interpret results correctly.

Complex tools with many parameters or behaviors need more documentation. Simple tools need less. This dimension scales expectations accordingly.

Parameters3/5

Does the description clarify parameter syntax, constraints, interactions, or defaults beyond what the schema provides?

Schema description coverage is 100% for both parameters, so the schema already documents type and value well. The description reinforces the same examples (AAPL, 0000320193, Moderna) and confirms type values are interchangeable, but adds limited new semantic information beyond what the schema states.

Input schemas describe structure but not intent. Descriptions should explain non-obvious parameter relationships and valid value ranges.

Purpose5/5

Does the description clearly state what the tool does and how it differs from similar tools?

The description leads with concrete user phrasings and states the core function: "full cross-source profile of a US public company in ONE parallel call." It clearly distinguishes itself from single-source lookups and lists the resource scope (SEC, XBRL, patents, contracts, FDA, H-1B, news, GLEIF), so an agent can identify exactly what this tool does.

Agents choose between tools based on descriptions. A clear purpose with a specific verb and resource helps agents select the right tool.

Usage Guidelines5/5

Does the description explain when to use this tool, when not to, or what alternatives exist?

It explicitly says "ALWAYS PREFER over chaining single-pack SEC/XBRL/news lookups when the user asks for a holistic view," giving both a when-to-use rule and an alternative. It also specifies acceptable input forms, notes that private companies return resolved:false rather than failing, and mentions person/place is not yet supported.

Agents often have multiple tools that could apply. Explicit usage guidance like "use X instead of Y when Z" prevents misuse.

Try in Browser

Glama MCP Gateway

Add one secure layer between your agents and this server.

TDQS

A4.3/5.0
Disambiguation5/5

Each tool has a clearly defined, distinct purpose. Even closely related tools like ask_pipeworx and ask_pipeworx_grounded are differentiated by use case (casual vs. high-stakes), and the prediction market tools each cover a specific function (research, edge detection, arbitrage, fill risk, tracking, cross-venue spreads). Detailed descriptions eliminate ambiguity.

Naming Consistency4/5

Tool names predominantly follow a verb_noun pattern (e.g., ask_pipeworx, compare_entities, resolve_entity), but a few use noun_noun or adjective_noun forms (e.g., entity_profile, recent_alerts). The naming is generally predictable and readable, with minor deviations from a strict pattern.

Tool Count3/5

The server offers 32 tools, which is above the typical 3-15 range for a well-scoped server. However, the vast domain (financials, prediction markets, news, memory, subscriptions, etc.) justifies the count. It is on the heavy side but still manageable with clear organization.

Completeness5/5

The tool surface is remarkably complete for the apparent domain: exploration (discover_tools, suggest_questions), identifier resolution (resolve_entity), data retrieval (ask_pipeworx, deep_research, entity_profile, compare_entities, recent_changes, validate_claim), prediction market analysis (full suite), memory (remember/recall/forget), subscriptions (subscribe/unsubscribe/list/recent_alerts), and extras (ENS, dependency scan, AI visibility). No obvious gaps exist.